Drug recall · March 12, 2014
Heparin Sodium Injection recall
Why: Subpotent; 18 month time point
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) For IV or SC use, Multi-Dose Vial, Rx only, NDC 63323-540-11, 25 vials in tray, each boxed vial individually labeled as: Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) For IV or SC use, Multi-Dose Vial, Rx only, NDC 63323-540-11.
- Lots / codes
Lot Number: 6004137, Expiration date: 06/2014
- Quantity
- 161,650 vials
- Company
- Fresenius Kabi USA, LLC, Grand Island, NY
- Distribution
- Nationwide
- Initiated
- January 22, 2014 · Voluntary: Firm initiated
- Classified
- March 5, 2014
- Reported
- March 12, 2014
- Ended
- May 24, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Heparin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.